References

Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis

10.1097/00000441-198805000-00005 · 1988 · External reference

Clinical uses of intravenous immunoglobulins

1988 · External reference

Clinical use of intravenous immunoglobulins

1986 · External reference

Treatment of Guillain–Barre syndrome with high-dose gammaglobulin

10.1212/wnl.38.10.1639 · 1988 · External reference

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study

10.1212/wnl.40.2.209 · 1990 · External reference

Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses

10.1212/wnl.50.2.398 · 1998 · External reference

Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing–remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group

10.1016/s0140-6736(96)09377-4 · 1997 · External reference

Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis

10.1212/wnl.50.5.1273 · 1998 · External reference

Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura

10.1016/0140-6736(93)92000-j · 1993 · External reference

Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use

10.1172/jci118488 · 1996 · External reference

Selectivity of recognition of variable (V) regions of autoantibodies by intravenous immunoglobulin (IVIg)

10.1006/clin.1994.1019 · 1994 · External reference

Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses

10.1111/j.1600-065x.1989.tb00031.x · 1989 · External reference

Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ

10.1097/00007890-199402270-00014 · 1994 · External reference

Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy

10.1111/j.1600-065x.1994.tb00854.x · 1994 · External reference

Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin

10.1006/clin.1994.1186 · 1994 · External reference

Cytokines and autoantibodies to cytokines

10.1002/stem.5530130303 · 1995 · External reference

Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells

10.4049/jimmunol.129.1.303 · 1982 · External reference

Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion

10.1172/jci117012 · 1994 · External reference

T cells in the lesion of experimental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins

10.1172/jci116136 · 1992 · External reference

Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases

10.1001/archneur.56.6.661 · 1999 · External reference

Normal immunoglobulin G protects against experimental allergic encephalomyelitis by inducing transferable T cell unresponsiveness to myelin basic protein

10.1002/(sici)1521-4141(199806)28:06<1823::aid-immu1823>3.0.co;2-f · 1998 · External reference

Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis

10.1093/intimm/5.12.1559 · 1993 · External reference

CD4+ murine T cell clones that express high levels of immunoglobulin binding belong to the interleukin 4-producing T helper cell type 2 subset

10.1084/jem.171.6.2171 · 1990 · External reference

Lymphocyte Fc receptors: the special case of T cells

10.1016/0167-5699(93)90168-k · 1993 · External reference

Lymphocyte Fc receptors: expression, regulation and function

10.1016/0161-5890(90)90019-v · 1990 · External reference

Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway

10.4049/jimmunol.161.7.3781 · 1998 · External reference

Pooled human immunoglobulin inhibits IL-4 but not IFN-gamma or TNF-alpha secretion following in vitro stimulation of mononuclear cells with Staphylococcal superantigen

10.1006/cyto.1998.0435 · 1999 · External reference

Modulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins: a possible mechanism of action in vascular diseases

10.1016/s0002-9440(10)65670-2 · 1998 · External reference

Down-regulation of lymphokine synthesis by intravenous gammaglobulin is dependent upon accessory cells

10.1046/j.1365-3083.1998.00299.x · 1998 · External reference

Mechanisms of action of intravenous immune globulin in immune-mediated diseases

10.1111/cei.1996.104.s1.3 · 1996 · External reference